logo
red bar

Home
Mission
Investigators
Transgenic Mouse Facility
Real-time PCR Core Facility
Human Tumor Bank Core Facility
 Career Opportunities
 Funding Opportunities
 Graduate Training in Cancer
   Cancer Cell Biology Track
   SCCCB Predoctoral Fellowship
   Cancer Center Training Grant
Seminars
In the News
 Related Links
 Site Index
 Software - Molecular Biology Tools
 UTMB Cancer Center
 UTMB Home Page

Faculty Investigator

Dr. Mark Hellmich

Mark R. Hellmich, Ph.D.

Associate Professor
Department of Surgery
email:mhellmic@utmb.edu

My major research interest is in the elucidation of signaling pathways regulated by heptahelical G-protein linked peptide hormone receptors of gastrointestinal (GI) tract, specifically those pathways coupled to the bombesin  and CCK/gastrin family of receptors.  Currently, my research activities are focused on:  1) defining the role of these peptide hormones and their receptors in regulating the interactions between epithelial and stromal cells during GI carcinogenesis, 2) define the mechanism by which mitogen activated protein kinases regulate peptide hormone-mediated release of intracellular Ca2+ from intracellular stores, and 3) characterizing the effects of intron 4 retention on the function of a novel splice-variant of the gastrin/CCK2 receptor expressed in esophageal, pancreatic and colorectal cancers.

Selected Publications

Levine L, Lucci JA 3rd, Pazdrak B, Cheng JZ, Guo YS, Townsend CM Jr, Hellmich MR. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Cancer Res.63:3495-502, 2003.

Levine L, Licci JA 3rd, Townsend CM Jr, Hellmich MR. Expression of gastrin-releasing peptide receptors in endometrial cancer. J Am Coll Surg.19:898-904, 2003.

Olszewska-Pazdrak B, Townsend CM Jr, Hellmich MR.  Agonist-independent activation of Src tyrosine kinase by a cholecystokinin-2 (CCK2) receptor splice variant. J Biol Chem. 279:40400-4, 2004.

Olszewska-Pazdrak B, Ives KL, Park J, Townsend CM Jr, Hellmich MR. Epidermal growth factor potentiates cholecystokinin/gastrin receptor-mediated Ca2+ release by activation of mitogen-activated protein kinases. J Biol Chem. 279:1853-60, 2004.

Chao C, Ives KL, Goluszko E, Kolokoltsov AA, Davey RA, Townsend CM Jr, Hellmich MR. Src regulates constitutive internalization and rapid resensitization of a CCK2 receptor splice variant. J Biol Chem, 280:33368-33373, 2005.

Chao C, Tallman ML, Ives KL, Townsend CM Jr, Hellmich MR.  Gastrointestinal hormone receptors in primary human colorectal carcinomas. J Surg Res, 129:313-321, 2005.

Chao C, Goluszko E, Lee Y-T, Kolokoltsov A A, Davey R A, Uchida T, Townsend Jr. C M, Hellmich MR.  Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1α expression and tumor growth. Oncogene, 26:1013-1019, 2007.

Hellmich MR and Evers BM.  Regulation of Gastrointestinal Normal Cell Growth. In: Physiology of the Gastrointestinal Tract 4th Ed. 2006, pp 435-458, Leonard R. Johnson (ed). Elsevier Academic Press, Burlington, MA USA.

Chao C, Hellmich MR.  CCK2 receptor splice variants in human gastrointestinal cancers, In Alternative Splicing in Cancer. 2006, pp 21-44, ISBN:81-7895-235-1, Julian P Venables (ed). Transworld Research Network, Kerala, India.

red bar
This site is published by John Helms for the Sealy Center for Cancer Cell Biology.
Copyright © 2003
The University of Texas Medical Branch. Please review our Privacy Policy and Internet Guidelines.
Last reviewed: November 5, 2008.